SCHEDULE: Wellington Management Discloses 0% Stake in Beta Bionics

Wellington Management Group and its affiliates filed an amended Schedule 13G, reporting no beneficial ownership in Beta Bionics, Inc. common stock.

Summary

• Wellington Management Group LLP, Wellington Group Holdings LLP, and Wellington Investment Advisors Holdings LLP filed an Amendment No. 1 to Schedule 13G.
• The filing reports 0.00 shares beneficially owned in Beta Bionics, Inc. common stock by the reporting persons.
• This represents 0.0% of the class of securities.
• The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It is a routine administrative update indicating no beneficial ownership by Wellington Management Group and its affiliates, providing no direct positive or negative implications for Beta Bionics' operational or financial performance.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures by institutional investors holding less than 20% of a company's stock, indicating passive investment intent. This particular filing, showing 0% ownership, suggests a complete divestment or a correction of a previous filing, which is a common administrative update.

Stakeholder Impact

• Minimal direct impact on shareholders, employees, customers, suppliers, and creditors, as the filing confirms no beneficial ownership by the reporting entities.

Key Dates

Keywords

Beta Bionics, Wellington Management, Schedule 13G, Common Stock, Beneficial Ownership, Institutional Ownership, SEC Filing